FDA pushes for more research on male breast cancer
POSTED: Sunday, July 20, 2014 - 11:15pm
UPDATED: Monday, July 21, 2014 - 1:29pm
A surprising new demographic could be added to breast cancer treatment trials: men.
On Monday, the FDA urged drug companies to include males in their trials.
Male breast cancer is rare. It only accounts for less than 1% of all breast cancer diagnoses world wide.
The National Cancer Institute says about 2,300 men will be diagnosed with breast cancer and about 430 will die from it.
Men are seldom included in breast cancer treatment trials and research, so there's an increased burden on those affected.
Director of Texas Tech Oncology and UMC Dr. Zeina Nahleh joins Daniel Marin to talk more about how why the FDA is pushing for more research.